iSpecimen (ISPC) Stock: Buy, Sell, or Hold?
ISPC - iSpecimen Inc. Common Stock
$1.08
-0.06 (-5.26%)
▼
5d:
-14.29%
30d:
-27.52%
90d:
-57.98%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 16, 2026
Get Alerted When ISPC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ISPC is down 14.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ISPC is down 14.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ISPC is currently trading at $1.08, which is considered oversold relative to its 30-day fair value range of $1.24 to $1.56.
Technical Outlook: Technically, ISPC is in a strong downtrend. Immediate support is located at $1.04, while resistance sits at $1.38. Short-term momentum is weak, with the stock down 5.3% recently.
Market Sentiment: ISPC scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.00 (+177.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ISPC is in a strong downtrend. Immediate support is located at $1.04, while resistance sits at $1.38. Short-term momentum is weak, with the stock down 5.3% recently.
Market Sentiment: ISPC scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.00 (+177.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.24 -
$1.56
Company Quality Score
40/100
(SELL)
Volume Confirmation
MODERATE
Confidence Score
47.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BEARISH: Downward momentum (-5.3%)
- BULLISH: Trading 177.8% below Wall St target ($3.00)
- WARNING: Composite score 40/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.24 -
$1.56
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.04
Resistance Level
$1.38
Current Trend
Strong Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Wall Street Target
$3.00
(+177.8%)
Revenue Growth (YoY)
-78.7%
Share & Embed Analysis
Last updated: October 03, 2026 8:45 PM ET
Data refreshes hourly during market hours. Next update: 9:45 PM
Data refreshes hourly during market hours. Next update: 9:45 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ISPC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$653 | 49 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$231 | 53 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$196 | 48 HOLD |
|
LH
Laboratory Corporation o… |
STRONG BUY
20 analysts |
$345 | 67 BUY |
